Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients

Apha-1-adrenergic receptor antagonists (α(1)-blockers) can suppress pro-inflammatory cytokines, thereby potentially improving outcomes among patients with COVID-19. Accordingly, we evaluated the association between α(1)-blocker exposure (before or during hospitalization) and COVID-19 in-hospital mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shilong, Jun, Tomi, Tyler, Jonathan, Schadt, Emilio, Kao, Yu-Han, Wang, Zichen, Konig, Maximilian F., Bettegowda, Chetan, Vogelstein, Joshua T., Papadopoulos, Nickolas, Parsons, Ramon E., Chen, Rong, Schadt, Eric E., Li, Li, Oh, William K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919772/
https://www.ncbi.nlm.nih.gov/pubmed/35295598
http://dx.doi.org/10.3389/fmed.2022.849222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919772/
https://www.ncbi.nlm.nih.gov/pubmed/35295598
http://dx.doi.org/10.3389/fmed.2022.849222

Ejemplares similares